Integrin signaling is activated during epithelial-mesenchymal transdierentiation (EMT) and cell migration, processes serving as models for carcinogenesis. We have shown that paxillin and p130Cas become highly tyrosine phosphorylated during these processes in NMuMG cells. Here, we examined the regulation of Fak and Pyk2, kinases implicated in this phosphorylation. Pyk2 became phosphorylated at the major autophosphorylation site (Tyr-402) and the potential Grb2-binding site (Tyr-881) during EMT. In contrast, phosphorylation of Fak at the corresponding autophosphorylation site (Tyr-397) occurred even in sedentary epithelial cells, whereas phosphorylation at Tyr-407 and Tyr-861 was induced during EMT. During cell migration, these phosphorylation events, except Fak Tyr-397, were augmented further, and phosphorylation of Fak Tyr-577 and the corresponding Pyk2 Tyr-580, both within the kinase activation loops, was also induced. In all cases, phosphorylation of the putative Grb2-binding site in Fak (Tyr-925) was almost undetectable. Although Fak and Pyk2 have several phosphorylation sites in common, Tyr-407 and Tyr-861 are unique to Fak. Our results revealed that Fak and Pyk2 are non-equivalent in the tyrosine phosphorylation events and thereby likely to evoke dierent downstream signaling cascades during EMT and cell migration of NMuMG cells. We also show that Fak Tyr-397 phosphorylation occurs exclusively at the cytoplasm, but not at focal contacts, in the sedentary epithelial cells. In contrast, all other tyrosine phosphorylated forms of Fak and Pyk2 are predominantly localized to focal adhesions and the cell periphery in motile cells, all colocalized with paxillin and p130Cas. Oncogene (2001) 20, 2626 ± 2635.
Introduction
An in vitro epithelial-mesenchymal transdierentiation (EMT) system provides a model for investigating the intracellular processes that accompany integrin activation (Miettinen et al., 1994) . Using in vitro EMT of normal murine mammary NMuMG epithelial cells as well as the cells migrating actively, we previously investigated intracellular events and showed that tyrosine phosphorylation of two focal adhesion proteins, paxillin and p130Cas, is the prominent event . It has been shown that p130Cas tyrosine phosphorylation acts to facilitate cell migratory activity (Cary et al., 1998; Klemke et al., 1998) . On the other hand, we have shown that paxillin and p130Cas, when they are overexpressed, can exert opposing eects on cell migratory activities through their tyrosine phosphorylation .
Protein tyrosine kinases (PTKs) Fak (Hanks et al., 1992; Schaller et al., 1992) and a Fak-related PTK, Pyk2 (also referred to as CAKb/RAFTK/CadTK) (Avraham et al., 1995; Earp et al., 1995; Lev et al., 1995; Sasaki et al., 1995; Herzog et al., 1997) are involved in directing the tyrosine phosphorylation of paxillin and p130Cas (Bellis et al., 1995; Li and Earp, 1997) . Association of Fak with paxillin and p130Cas (Bellis et al., 1995; Tachibana et al., 1995; Harte et al., 1996; Polte and Hanks, 1997) as well as association of Pyk2 with paxillin and p130Cas (Astier et al., 1997; Hiregowdara et al., 1997; Li and Earp, 1997; Ostergaard et al., 1998) have also been shown. Fak and Pyk2 share about 45% overall sequence similarity. Fak tyrosine phosphorylation occurs at six or more sites in vivo (Calalb et al., 1995; Schlaepfer and Hunter, 1996) : two sites are located within the N-terminal domain (Tyr 397 and Tyr 407), two sites within the putative kinase activation loop (Tyr 576 and Tyr 577), and two sites within the C-terminal domain (Tyr 861 and Tyr 925). Activation of the kinase activities of Fak ®rst leads to autophosphorylation, which occurs at Tyr 397; moreover, Tyr 397 can also be phosphorylated by c-Src (Calalb et al., 1995) . Phosphorylated Tyr 397 is thought to have downstream signaling roles including recruitment and activation of Src family PTKs (Schlaepfer et al., 1994; Dikic et al., 1996) , phosphatidylinositol-3-kinase (Chen et al., 1996) and phospho-lipase Cg (Zhang et al., 1999) . The other phosphorylation sites in Fak are preferentially phosphorylated by Src family PTKs, which may be recruited to the Fakcontaining signaling complex (Calalb et al., 1995 (Calalb et al., , 1996 Schlaepfer and Hunter, 1996) . Phosphorylation of Tyr 567 and 577 is required for maximal Fak catalytic activity (Calalb et al., 1995) . Phosphorylation at the Cterminal Tyr 861 and 925 creates binding sites for the src homology 2 (SH2)-containing proteins, which are thus likely to participate in the activation of the downstream signaling. An adaptor molecule, Grb2, can bind to the phosphorylated Tyr 925, and has therefore been hypothesized to contribute to activation of downstream targets such as the ERK2/MAP kinase cascade (Schlaepfer et al., 1994) . On the other hand, the signaling molecule(s) downstream of Tyr 861 phosphorylation are still unknown. Four of the tyrosine phosphorylation sites in Fak are conserved at analogous positions in Pyk2 (Tyr 402, 579, 580 and 881, which correspond to Tyr 397, 576, 577 and 925 of Fak, respectively), and a similar or equivalent role has been assumed or demonstrated for each of the analogous tyrosines (reviewed in Schlaepfer et al., 1999) . For example, it has been shown that Fak and Pyk2 can participate in largely overlapping, though not identical, intracellular integrin signaling pathways (Schaller and Sasaki, 1997; Sieg et al., 1998) .
Unlike Fak, Pyk2 has the unique property of being regulated by intracellular calcium signaling (Earp et al., 1995; Lev et al., 1995; Dikic et al., 1996; Yu et al., 1996; Cazaubon et al., 1997; Della Rocca et al., 1997; Solto et al., 1998; Felsch et al., 1998) . These two PTKs can thus be regulated in dierent ways. For example, it has been shown that the kinase activities of Fak and Pyk2 in rat aortic smooth muscle cells are dierentially regulated during cell adhesion to extracellular matrices, and by several soluble factors which evoke intracellular calcium signaling (Zheng et al., 1998) . Marked dierences in the subcellular localization of these proteins have also been indicated: a large fraction of Pyk2 is localized at perinuclear areas whereas Fak is primarily localized at focal adhesions (Schaller and Sasaki, 1997; Sieg et al., 1998) .
In order to understand the signaling pathways leading to the tyrosine phosphorylation of paxillin and p130Cas during EMT and cell migration, we examined here the regulations and the activation states of Fak and Pyk2. To this end, we employed phosphorylation site-speci®c antibodies against a panel of tyrosine phosphorylation sites of Fak and Pyk2. Our results revealed that both Fak and Pyk2 are dierently regulated during EMT and cell migration of NMuMG cells, despite the fact that both kinases are activated by the same stimuli. We also found that Tyr-397-phosphorylated Fak molecules are diusely distributed in the cytoplasm in the sedentary epithelial cells (i.e., epithelial cells cultured to con¯uence), whereas they are predominantly localized in focal complexes at the cell periphery and focal adhesions underneath the cell body in the sedentary mesenchymal cells (i.e., cells treated with TGFb1) or in epithelial or mesenchymal cells migrating actively. Our analysis also reveals a potential dierence in the downstream signaling between Fak and Pyk2 during cell migration.
Results

Nonequivalent tyrosine phosphorylation of Fak and Pyk2 during EMT of NMuMG cells
In order to understand the intracellular events that accompany integrin activation, we have started to analyse NMuMG cells, which undergo EMT in response to treatment with TGFb1, and demonstrated that tyrosine phosphorylation of paxillin and p130Cas is a prominent event during EMT and cell migration . Here we examined NMuMG cells by focusing on two tyrosine kinases, Fak and Pyk2, both of which have been implicated in the phosphorylation of paxillin and p130Cas (Bellis et al., 1995; Li and Earp, 1997) .
We previously examined the tyrosine phosphorylation level of Fak using generic anti-phosphotyrosine antibody 4G10, and reported that Fak is well phosphorylated in sedentary epithelial NMuMG cells (i.e., cells cultured to con¯uent density), and that slight augmentation of its phosphorylation was detected during EMT ; also see Figure 1 ). On the other hand, we here found that tyrosine phosphorylation of Pyk2, also detected using 4G10, was almost undetectable in the sedentary epithelial NMuMG cells but highly induced after cells were treated with TGFb1 ( Figure 1 ). The protein levels of Fak and Pyk2 were almost unchanged during EMT (Figure 1 ). In these experiments, cell lysates were prepared from con¯uent cell cultures and hence their migratory activities were minimal.
Both Fak and Pyk2 have multiple sites of tyrosine phosphorylation (Schlaepfer et al., 1999) . To identify the phosphorylation sites, we next employed phosphor- Figure 1 Pyk2 becomes highly tyrosine phosphorylated during in vitro EMT of NMuMG cells. Levels of tyrosine phosphorylation of Pyk2 from NMuMG cells of the epithelial phenotype (7TGF) or the mesenchymal phenotype (+TGF, 2 ng/ml for 48 h at 378C) were analysed by immunoprecipitating Pyk2 protein from RIPA cell lysates (500 mg each), followed by SDS ± PAGE and sequential immunoblotting using an anti-phosphotyrosine antibody (4G10; upper panel) and anti-Pyk2 antibody (lower panel), as described under Materials and methods. The same analysis with Fak and paxillin, which we have already described previously , was also performed simultaneously and is shown for comparison. NMuMG cells reached con¯uence before lysis ylation site-speci®c antibodies against each potential tyrosine residue. As shown in a previous report , we ®rst examined NMuMG cells cultured under con¯uent conditions, which had been treated or not treated with TGFb1. As shown in Figure 2a , we found that Tyr-397 of Fak was highly phosphorylated even in these sedentary epithelial cells, and that the level of the phosphorylation was almost unchanged during EMT induced by the TGFb1-treatment. Phosphorylation of Tyr-397 of Fak, on the other hand, disappeared when the epithelial cells were kept in suspension in the absence of serum (Figure 2c ). In contrast, phosphorylation at Tyr-407 and 861 of Fak, was almost undetectable in the sedentary epithelial cells, and was signi®cantly induced during EMT (Figure 2a ). In the case of Pyk2, phosphorylation at all of the tyrosines was almost undetectable in the sedentary epithelial cells, and Tyr-402 and 881 became highly phosphorylated during EMT (Figure 2b ). Phosphorylation at Tyr-576, 577 and 925 of Fak, and Tyr-579 and 580 of Pyk2 was almost undetectable in both of these conditions (Figure 2a,b) . Tyr-397 and 925 of Fak correspond to Tyr-402 and 881 of Pyk2, respectively, and tyrosine residues corresponding to Tyr-407 and Tyr-861 of Fak are absent in Pyk2. Thus, the patterns of tyrosine phosphorylations of Fak and Pyk2 that occurred in the sedentary NMuMG cells with both epithelial and mesenchymal phenotypes were not equivalent.
Tyrosine phosphorylation of Fak and Pyk2 during cell migration of NMuMG cells
We also examined the tyrosine phosphorylation of Fak and Pyk2 in actively migrating cells by preparing cell lysates from cells cultured under sparse conditions. Active migration of NMuMG cells cultured under sparse densities has been well documented through recording cells using time-lapse video micrography . As shown in Figure 2 , all of the tyrosine phosphorylation events of Fak and Pyk2 observed during EMT also took place in migrating cells. These phosphorylation events were detected in migrating cells which were not treated with TGFb1, at higher levels than in the sedentary cells treated with TGFb1; and the levels became much higher in the migrating cells pretreated with TGFb1 ( Figure 2 ). Moreover, phosphorylation at Tyr-577 of Fak and Tyr-580 of Pyk2 became clearly detectable in the migrating cells (Figure 2a, b) . Phosphorylation of Tyr-576 of Fak also became detectable during cell migration, though the level of phosphorylation was still very low. On the other hand, phosphorylation at Tyr-397 of Fak was only slightly increased in the migrating cells, as compared to that in con¯uent cells ( Figure 2a ). Phosphorylation at Tyr-925 of Fak and Tyr-579 of Pyk2 was still almost undetectable in the migrating cells (Figure 2a,b) , though the reactivity of these phosphorylation site-speci®c antibodies has been well documented (Sieg et al., 2000 ; our unpublished results).
Tyr-397-phosphorylated Fak was diffusely distributed in the cytoplasm of NMuMG cells with the sedentary epithelial phenotype
Our results shown above revealed that Fak is well phosphorylated at Tyr-397 even in the sedentary epithelial cells, where little focal adhesions were formed. Tyr-397 is the autophosphorylation site of Fak; and Fak has been shown to be activated and to function primarily at focal complexes and/or focal adhesions (Hanks et al., 1992; Kornberg et al., 1992; Schaller et al., 1992) . We therefore examined the Figure 2 Analysis of Fak and Pyk2 tyrosine phosphorylation using phosphorylation site-speci®c antibodies. (a,b), Phosphorylation of each tyrosine residue of Fak and Pyk2 during EMT and cell migration. RIPA cell lysates were prepared from NMuMG cells not treated (lanes 1 and 3) or treated (lanes 2 and 4) with TGFb1 and cultured under con¯uent (lanes 1 and 2) or sparse (lanes 3 and 4) conditions as described under Materials and methods, separated on SDS ± PAGE and subjected to immunoblotting analysis using various phosphorylation site-speci®c antibodies against phosphorylated tyrosine residues of Fak (a) and Pyk2 (b), as indicated. Each lane contained 20 mg of cell lysate. Membrane ®lters were freshly prepared for each immunoblotting in order to avoid possible artifacts due to tyrosine dephosphorylation during repeated immunoblotting steps. Protein levels of Fak and Pyk2 are also shown using the respective protein-speci®c antibodies. (c) Tyr-397 phosphorylation of Fak in cells kept in suspension and during cell adhesion. RIPA cell lysates were prepared from NMuMG cells trypsinized and kept in suspension for 30 min in the absence of serum (lane 1) or cultured normally on dishes untreated (lane 2) or treated (lane 3) with TGFb1, followed by SDS ± PAGE and immunoblotting analysis using antibodies speci®c for Fak when phosphorylated at Tyr-397 (pY397) or total Fak protein (Fak). NMuMG cells reached con¯uence before trypsinization or lysis. (d), Schematic drawings of potential tyrosine phosphorylation sites of Fak and Pyk subcellular localization of the Tyr-397-phosphorylated form of Fak, together with other tyrosine phosphorylated Fak species. As shown in Figure 3a , immunostaining of the epithelial cells cultured under con¯uent conditions revealed that the Tyr-397-phosphorylated form of Fak was diusely distributed in the cytoplasm. On the other hand, in NMuMG cells with the mesenchymal phenotype cultured under con¯uent conditions, Tyr-397-phosphorylated Fak was detected predominantly at focal adhesions located at each end of actin stress ®bers ( Figure  3a) , and was colocalized with paxillin and p130Cas (data not shown). Tyr-407-and Tyr-861-phosphorylated forms of Fak, which were not detected in the sedentary epithelial cells, were also localized in focal adhesions in the sedentary mesenchymal cells ( Figure  3a) . Therefore, unlike Tyr-407-and Tyr-861-phosphorylation, phosphorylation of Tyr-397 of Fak can take place even in the cytoplasm, and this cytoplasmic phosphorylation is not correlated with the formation of focal adhesions and stress ®bers, at least in NMuMG cells.
Localization of phosphorylated Pyk2 at focal adhesions in NMuMG cells with the mesenchymal phenotype
Unlike phosphorylation of Fak, tyrosine phosphorylation of Pyk2 was well correlated with focal adhesion formation; and tyrosine phosphorylated Pyk2 localized to focal adhesions (Figure 3b) . A previous report showed that Pyk2, as detected using an generic antiPyk2 antibody raised against a C-terminal 250 amino acid-fused GST protein in rabbit, seems to be localized primarily in the cytoplasm (Zheng et al., 1998) . We also detected diuse cytoplasmic signals of Pyk2 in the sedentary epithelial NMuMG cells by using antibody (clone 11) generated by immunizing mice with the Cterminal 160 residues, although this antibody did not give signals in the mesenchymal cells where Pyk2 was highly tyrosine phosphorylated ( Figure 3b) . Thus, phosphorylated Pyk2 is localized at focal adhesions in NMuMG cells with the mesenchymal phenotype, while the unphosphorylated Pyk2 is localized diusely in the cytoplasm in NMuMG cells with the sedentary epithelial phenotype. Figure 3 Intracellular localization of tyrosine-phosphorylated species of Fak and Pyk2 in NMuMG cells with epithelial and mesenchymal phenotypes at con¯uence. Cells grown to con¯uence after they were treated with TGFb1 (+TGF) or left untreated (7TGF) were ®xed, labeled and subjected to microscopic analysis as described under Materials and methods. Fak (a) and Pyk2 (b) proteins and each of their tyrosine-phosphorylated species were visualized using rabbit phosphorylation site-speci®c antibodies, as indicated, coupled with Cy3-conjugated anti-rabbit IgG (shown in red). F-actin was visualized with Oregon Green-conjugated phalloidin (shown in green). Paxillin was also visualized (shown in blue), using mouse anti-paxillin antibody coupled with Cy5-conjugated anti-mouse IgG antibody to show the focal adhesions in the TGFb1-treated cells, or their absence in the TGF-untreated cells. Merged images are shown. Dierential interference contrast (DIC) images of the same ®eld (second from the right) are shown in the right column. In the left column in a, note that Fak molecules phosphorylated at Tyr-397 were found to be localized in the cytoplasm in NMuMG cells with the sedentary epithelial phenotype, whereas they are well colocalized with paxillin and partially with F-actin at focal adhesions in NMuMG cells with the mesenchymal phenotype; and focal adhesions in these cells are hence shown in purple to white. In the second column from the right in (b), Pyk2 was detected in the cytoplasm in the epithelial cells using anti-Pyk2 antibody (red signals in the cytoplasm). However, the Pyk2 signals were almost undetectable in the mesenchymal cells and hence focal adhesions were not purple or white (lower panel), while Tyr-402-and 881-phosphorylated forms of Pyk2 were clearly detected at focal adhesions in these mesenchymal cells. Thus, this anti-Pyk2 antibody seems to be very inecient in detecting phosphorylated Pyk2 molecules and/or Pyk2 molecules localized at focal adhesions. Bars represent 20 mm Subcellular localization of tyrosine-phosphorylated forms of Fak and Pyk2 in migrating NMuMG cells Each tyrosine-phosphorylated form of Fak and Pyk2 molecules was then visualized in situ in migrating NMuMG cells. To prepare cells actively migrating in a certain direction, cells were induced to migrate by manually scratching con¯uent cell cultures. Using these cell preparations, we have shown that tyrosinephosphorylated forms of paxillin are localized in focal complexes at the leading edges of cells, which may correspond to the lamellipodia structure, and focal adhesions formed underneath the cell body . p130Cas tagged with EGFP was also detected both at focal complexes and focal adhesions of migrating cells, well colocalized with paxillin ( Figure  4) . Each tyrosine-phosphorylated form of Fak and Pyk2 was also found to be localized both of these structures in the migrating NMuMG cells with the epithelial phenotype, again well colocalized with both paxillin and p130Cas (Figure 4a,b) . It should be noted that, unlike in the case of the sedentary epithelial cells, Tyr-397-phosphorylated Fak was also predominantly localized at focal complexes and focal adhesions of the epithelial cells when cells were migrating (Figure 4a) , suggesting that the TGF treatment is not necessary for the focal adhesion localization of Tyr-397-phosphorylated Fak. For each phosphorylated form of Fak and Pyk2, there seemed to be some dierence in the intensities of the signal depending on the subcellular localization of the protein. It may be of interest to know whether certain types of phosphorylation occur predominantly in certain areas of cells. However, our analysis and methods used here do not address this point precisely.
Similar visualization of tyrosine-phosphorylated Fak and Pyk2 molecules was also performed with migrating NMuMG cells with the mesenchymal phenotype. In the mesenchymal NMuMG cells, stress ®bers seemed to be much more highly bundled and much more robust focal adhesions appeared to be formed than those in the migrating epithelial NMuMG cells ; also see Figure 5 ). All of the phosphorylated forms of Fak and Pyk2, including Fak phosphorylated at Tyr-577 and Pyk2 phosphorylated at Tyr-580, which were highly induced only in the migrating mesenchymal cells (see Figure 2) , were predominantly detected both at focal complexes and focal adhesions, well colocalized with paxillin ( Figure  5 ) and p130Cas (data not shown).
Both Fak and Pyk2 are activated during EMT and cell migration, but not in the sedentary epithelial NMuMG cells
We also examined the kinase activities of Fak and Pyk2 in vitro. Cell lysates were prepared from NMuMG cells not treated or treated with TGFb1 and also cultured under con¯uent or sparse conditions. Controls included cell lysates prepared from cells kept in suspension in the absence of serum, in which all phosphorylation of Fak including that of Tyr-397 (see Figure 2c ), as well as of Pyk2 (data not shown), disappeared. Fak and Pyk2 were immunoprecipitated from these cell lysates using the appropriate antibodies, and subjected to in vitro kinase assays using poly (GluTyr) as a substrate. As shown in Figure 6 , immunoprecipitates of both kinases exhibited very similar, or only slightly higher, levels of activities in the sedentary epithelial NMuMG cells as compared to those in Figure 4 Intracellular localization of each tyrosine-phosphorylated species of Fak and Pyk2 in migrating NMuMG cells with the epithelial phenotype. TGF-untreated NMuMG cells were induced to migrate by manually scratching con¯uent cell cultures and ®xed 4 h later as described under Materials and methods. Each tyrosine-phosphorylated species of Fak (a) and Pyk2 (b), as indicated, was visualized using the phosphorylation site-speci®c antibodies coupled with Cy3-conjugated anti-rabbit IgG, and is shown in the left column. p130Cas and paxillin proteins of the same ®elds were simultaneously visualized using EGFP-tagged p130Cas and mouse anti-paxillin antibody coupled with Cy5-conjugated anti-mouse IgG, and are shown in the second and third columns from the left, respectively. Merged images of the three left columns are shown in the right-most column, where each tyrosine-phosphorylated species of Fak and Pyk2 is shown in red, p130Cas in green and paxillin in blue. Bars represent 20 mm Differential activation of Fak and Pyk2 during EMT and cell migration K Nakamura et al suspended cells. On the other hand, the kinase activities of these immunoprecipitates increased by at least twofold in the sedentary mesenchymal cells as well as in the migrating cells with either phenotype ( Figure 6 ). As compared to the activities in the sedentary mesenchymal cells, the kinase activities of Pyk2 in immunoprecipitates was elevated further when cells were actively migrating (Figure 6b ). It should be noted, however, both Fak and Pyk2 immunoprecipitants prepared under this experimental condition may contain several other protein tyrosine kinases that associate with Fak and Pyk2. Under harsher conditions for the preparation of cell lysates to avoid such association of other kinases, such as using RIPA buer (see Materials and methods), however, the kinase activities of Fak and Pyk2 have been known to be inactivated. Our in vitro assays indicated that the kinase activity of Fak appears to stay at a basal level in the sedentary epithelial cells. Thus, phosphorylation of Tyr-397 of Fak in the sedentary epithelial cells does not re¯ect the activation of the kinase activity. Our results also indicated that both Pyk2 and Fak appear to be activated during EMT and cell migration of NMuMG cells; however, the mechanisms of their activation are dierent.
Discussion
Using phosphorylation site-speci®c antibodies, we examined here the phosphorylation of each potential Figure 2 , and subjected to in vitro kinase assays using poly (Glu-Tyr) as a substrate. The relative catalytic activities, determined as described under Materials and methods, are shown. The control included TGF-untreated cells kept in suspension for 30 min in the absence of serum, to show the basal levels of activities of these kinases. Error bars represent the s.d. of three independent experiments Oncogene Differential activation of Fak and Pyk2 during EMT and cell migration K Nakamura et al tyrosine residue of two focal adhesion-localizing tyrosine kinases, Fak and Pyk2, in NMuMG cells during EMT, which is induced by the addition of TGF b1, and during active cell migration, which is induced by culturing cells at sparse cell density or scratching con¯uent cultures. All of the tyrosine phosphorylation events in Fak and Pyk2 take place not only during EMT but also during cell migration of the epithelial cells; thus, these changes are not events uniquely evoked by the addition of TGF b1. Our previous analysis using a generic anti-phosphotyrosine antibody, 4G10, revealed that Fak is signi®cantly phosphorylated even in the sedentary epithelial cells. In the current study, we found that Pyk2 is not tyrosine phosphorylated in the sedentary epithelial cells, but becomes highly phosphorylated during EMT and cell migration. Similar dierences in the regulation of tyrosine phosphorylation of Fak and Pyk2 have been reported previously; for example, in GN4 rat liver epithelial cells and RSMC rat aortic smooth muscle cells during angiotensin II treatment (Li and Earp, 1997; Brinson et al., 1998) . In those cells, Fak is maximally tyrosine phosphorylated even in the quiescent cells, while Pyk2 becomes highly phosphorylated only after the angiotensin treatment, though any information as to phosphorylation of individual tyrosine residues were not provided. Our analysis dealt with phosphorylation of each tyrosine residue of Fak and Pyk2, and revealed several novel ®ndings with regard to the multiple sites of tyrosine phosphorylation of Fak and Pyk2 and their qualitative dierences during integrin activation.
Non-equivalent phosphorylation and possible different downstream signaling events involving Fak and Pyk2 during EMT and cell migration
Our results revealed that phosphorylation of four tyrosine residues of Fak 407, 577 and 861) and three tyrosine residues of Pyk2 (Tyr 402, 580 and 881) took place during EMT and/or active cell migration. Fak Tyr-397 and Pyk2 Tyr-402 both correspond to the autophosphorylation site, surrounded by the same SH2 binding motif (pTyr-AlaGlu-Ile), and hence thought to have equivalent roles for the recruitment of SH2-containing signaling molecules such as Src-family kinases, which may then participate in phosphorylating other sites of Fak and Pyk2 (Schlaepfer et al., 1994; Xing et al., 1994) . Both Fak Tyr-577 and Pyk2 Tyr-580 are located within the kinase activation loop, and are believed to contribute to the regulation of the kinase activities (Calalb et al., 1995) . On the other hand, Fak Tyr-861 and Pyk2 Tyr-881 appear to be nonequivalent. The SH2-binding motif surrounding Pyk2 Tyr-881 is pTyr-Leu-Asn-Val, and corresponds to that of Tyr-925 of Fak (pTyr-GluAsn-Val) rather than to that of Tyr-861 of Fak (pTyrGln-Pro-Val). Indeed, both phosphorylation of Pyk2 Tyr-881 and Fak Tyr-925 has been shown to create an SH2-binding site for the Grb2 (reviewed in Schlaepfer et al., 1999) . However, phosphorylation of Fak Tyr-925 is not detected in NMuMG cells under our experimental conditions. Moreover, Tyr-861 of Fak is unique to Fak and no corresponding tyrosine residue presents in Pyk2. Tyr-407 is also unique to Fak, which is surrounded by pTyr-Thr-Met-Pro. Therefore, the tyrosine phosphorylation events that occur on Fak and Pyk2 during EMT and cell migration of NMuMG cells are not equivalent, and hence likely to contribute to the activation of dierent downstream signaling cascades. The SH2-containing signaling proteins bound to Tyr-407 and Tyr-861 of Fak remain to be identi®ed.
Tyr-397-phosphorylated but kinase-inactive form of Fak is present in the cytoplasm of the sedentary epithelial cells
Our results also revealed that Tyr-397 of Fak is constitutively phosphorylated even in the sedentary epithelial NMuMG cells, in which integrin activation is minimal and little focal adhesions are formed. Moreover, little augmentation of the Tyr-397 phosphorylation was observed during EMT and cell migration. Phosphorylation at other sites such as Tyr-407, 577 and 861 of Fak, on the other hand, became highly induced. Our analysis also revealed that the Tyr-397-phosphorylated form of Fak molecules was present mostly in the cytoplasm in the sedentary epithelial cells, while it localizes to focal complexes and focal adhesions during EMT and cell migration. Tyr-407, 577 and 861 phosphorylated forms of Fak are also localized to focal complexes and focal adhesions. Tyr-397 corresponds to the autophosphorylation site of Fak (Schlaepfer et al., 1994) . Activation of the kinase activity of Fak, which accompanies the Tyr-397 phosphorylation, has been shown to occur, in general, when integrins are activated (Kornberg et al., 1992) . However, our in vitro assay revealed that the kinase activity of Fak stays near the basal level in the sedentary epithelial cells. Thus, phosphorylation of Tyr-397 of Fak in the sedentary epithelial cells does not re¯ect the activation of the kinase activity, nor correlate with integrin activation in NMuMG cells.
It should be noted that Tyr-397 is not necessarily phosphorylated only by the autophosphorylation activity of Fak, but also can be phosphorylated by other kinases . We also showed that Fak Tyr-397 is almost completely dephosphorylated when the sedentary epithelial NMuMG cells are kept in suspension in the absence of serum. Moreover, we have shown that Fak is highly tyrosine phosphorylated during decidualization of human endometrial stroma cells, where focal contacts had almost disappeared (Maruyama et al., 1999) . Thus, regulation of the tyrosine phosphorylation of Fak, especially at Tyr-397, seems to be more complicated than is generally believed primarily based on studies using ®broblast cells as a model system. Questions thus remain regarding the biological signi®cance of the Fak Tyr-397 phosphorylation in the cytoplasm and how the Tyr-397 phosphorylation is disconnected from the onset of the downstream signaling cascades in the sedentary epithelial cells where integrins are not substantially activated.
Tyrosine phosphorylated forms of Pyk2 localize to focal adhesions and focal complexes
Several reports have shown that Pyk2 is localized predominantly in the cytoplasm and the perinuclear areas (Schaller and Sasaki, 1997; Sieg et al., 1998; Zheng et al., 1998) . We also con®rmed diuse cytoplasmic staining of Pyk2 in the sedentary epithelial NMuMG cells using an anti-Pyk2 monoclonal antibody. However, we observed that Pyk2 signals detected with this antibody almost disappeared when cells were dierentiated into the mesenchymal phenotype. On the other hand, our results clearly indicated that Pyk2, when tyrosine phosphorylated at Tyr-402, 580 and 881 in the context of active cell migration or EMT, is predominantly localized at focal complexes and focal adhesions, suggesting that these are the main areas where the tyrosine-phosphorylated Pyk2 functions. Therefore, some generic anti-Pyk2 antibody appeared to preferentially recognize the unphosphorylated form of Pyk2 and/or Pyk2 localized in the cytoplasm. We did not detect tyrosine-phosphorylated forms of Pyk2 in the cytoplasm or perinuclear areas.
Several reports have demonstrated possible signaling pathways leading to the cell migratory activities, which are evoked through Fak tyrosine phosphorylation (Cary et al., 1998; Sieg et al., 1998; Owen et al., 1999) . In the case of Pyk2, however, little is known about the involvement in molecular processes regulating cell migratory activities. Moreover, several types of cells such as normal ®broblasts do not express Pyk2 (Dikic et al., 1998; Li et al., 1998) , and hence Pyk2 may not be essential for the basic machinery to carry out the integrin-mediated cell migration. It remains to be established to what extent Pyk2 phosphorylation and activation contributes to the regulation of the cell migration activity, or how much it instead contributes to other intracellular regulations, such as regulations of ion channels (Lev et al., 1995) , that may incidentally occur during integrin activation and cell migration.
How do the epithelial cells initiate intracellular signaling for cell migration?
The relationship between activations of Fak and Pyk2 and phosphorylations of paxillin and p130Cas is the next important question to be investigated. This may be closely related to the downstream SH2-containing signaling proteins that are recruited to each tyrosine phosphorylation site of Fak and Pyk2. A major question also remains concerning which intracellular signaling molecule(s) initially perceives the extracellular stimuli to evoke the signaling cascades for the phosphorylation of Fak and Pyk2, culminating in cell migration. Moreover, Fak and Pyk2 may intercommunicate with each other. It has been shown that Pyk2 can phosphorylate Fak, possibly at Tyr-407 (Li et al., 1999) , which then creates a potential binding site for SH2-containing protein(s) (Schlaepfer et al., 1999) . Potential inhibition of Pyk2 by Fak during cell adhesion has also been demonstrated by expressing Fak in Fak-null ®broblast cells . One possible scenario to induce epithelial cell migration could be that intracellular calcium signaling, which can be evoked by a variety of factors present in serum or ECMs, may ®rst cause an activation of Pyk2 in the cytoplasm, which in turn results in Fak phosphorylation, in addition to Tyr-397; and downstream signaling cascades of Fak as well as Pyk2 may thereby become activated, concomitant with the integrin activation. Further study of these points should be conducted to gain further understanding of EMT and cell migration at molecular levels, since these processes serve as basic models for the study of cancer invasion and metastasis.
Materials and methods
Cell culture
NMuMG cells (CRL 1639) with a passage number of 15 were obtained from American Type Culture Collection [ATCC] (Rockville, MD, USA) and cultured as described before (Miettinen et al., 1994; Nakamura et al., 2000) . NMuMG cells expressing EGFP-tagged p130Cas were described previously . For transdierentiation into the mesenchymal phenotype, 8610
5 NMuMG cells were seeded in a 9 cm culture dish (Beckton Dickinson, Franklin Lakes, NJ, USA), and 24 h later 2 ng/ml TGF b1 (R&D Systems, Minneapolis, MN, USA) was added, and cells were cultured further for 48 h as previously described (Miettinen et al., 1994) . For analysis of the epithelial phenotype, 8610 5 cells were seeded in a 9 cm culture dish and cultured for 3 days. Both the epithelial and mesenchymal cells reached con¯uence under these conditions. To examine cells under sparse culture conditions, 4610 5 cells not treated or treated with TGFb1 were seeded in a 9 cm culture dish and harvested on the next day.
Antibodies
Rabbit antibodies against Fak and paxillin were described previously (Tobe et al., 1996; Mazaki et al., 1998) . Mouse monoclonal anti-Pyk2 (clone 11) and rabbit anti-paxillin antibodies were purchased from Transduction Laboratories (Lexington, KY, USA). Mouse monoclonal anti-phosphotyrosine (clone 4G10) and rabbit anti-Pyk2 were from Upstate Biotechnology (Lake Placid, NY, USA). Cy3, Cy5 or HRPconjugated secondary antibodies against rabbit or mouse IgG, generated in donkey, were from Jackson ImmunoResearch Lab. (West Grove, PA, USA). Phosphorylation site-speci®c antibodies against FAK (pY397, pY407, pY576, pY577, pY861 and pY925) and Pyk2 (pY402, pY579, pY580 and pY881), all generated in rabbits, were obtained from BioSource International (Camarillo, CA, USA).
Immunoblotting analysis
Cell lysates were prepared with RIPA buer [1% NP-40, 0.1% SDS, 1% sodium deoxycholate, 150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA, 1 mM Na 3 VO 4 , 1 mM PMSF, 1% aprotinin, 2 mg/ml leupeptin and 3 mg/ml pepstatin A] as previously described (Sabe et al., 1994) . For immunoblotting, 20 mg of each cell lysate was separated by 8% SDS ± PAGE, transferred to membrane ®lters (Immobilon P, Millipore Corp., Bedford, MA, USA), and subjected to immunoblotting analysis as previously described (Sabe et al., 1994) . Antibodies retained on the ®lter membranes were visualized by horseradish peroxidase-conjugated donkey antirabbit or anti-mouse IgG secondary antibodies (Jackson ImmunoResearch Lab. Inc.), coupled with an enzyme-linked chemiluminescence method according to the manufacturer's instructions (Amersham Life Science Inc., Arlington Heights, IL, USA). For immunoprecipitation, 500 mg of each cell lysate was used.
Indirect immunofluorescence
8610
4 NMuMG cells were seeded into each 3.5 cm culture dish with a hole at the bottom where a number 0 glass coverslip was attached (MatTek Corporation, Ashland, MA, USA), and 24 h later, cells were treated or not treated with TGFb1 and cultured further for 48 h. To analyse motile cells, con¯uent cultures of cells were scratched manually with the needle of a 10 ml syringe (Hamilton Company, Carson, NV, USA). Wound regions were allowed to heal for 2 ± 4 h prior to analysis. Cells were then ®xed with 3.7% paraformaldehyde (Sigma Chemical Co.) in HBSS for 20 min at room temperature and subjected to indirect immuno¯uorescent assay, as described previously . For double staining with Pyk2 and paxillin, mouse anti-Pyk2 antibody and rabbit anti-paxillin antibody were used. F-actin was visualized by incubation for 1 h with Oregon Green phalloidin (Molecular Probes, Eugene, OR, USA) diluted 1 : 200. Confocal images were acquired using a confocal laserscanning microscope (model 510; Carl Zeiss, Inc., Oberkochen, Germany).
In vitro kinase assay
In vitro kinase activities of Fak and Pyk2 were measured as described previously (Cary et al., 1998 ) using a Protein Kinase Assay kit (Sigma Chemical Co.). In brief, cells were lysed with 1% NP-40 buer [1% Nonidet P-40, 150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA, 1 mM NaV 3 O 4 , 1 mM PMSF, 1% aprotinin, 2 mg/ml leupeptin and 3 mg/ml pepstatin A]. Five hundred micrograms of lysates were immunoprecipitated with anti-FAK or antiPyk2 polyclonal antibody, followed by incubation with Protein A-Sepharose 4B. Every half of the immune complexes was incubated in the kinase buer in the presence of 0.1 M ATP and 0.2 mg/ml of poly-glutamyltyrosine [Glu : Tyr=4 : 1] for 30 min at 378C. The supernatant was recovered by centrifugation, subjected to immunoblotting analysis using anti-phosphotyrosine antibodies (clone and analysed with an enzyme-linked chemiluminescence method as described above. The densities of corresponding bands on the ®lm were scanned with a Color One scanner (Apple, Tokyo, Japan) using the software supplied with the scanner and measured by using NIH Image 1.61 software. Amounts of Fak and Pyk2 proteins in immune complexes were quanti®ed by separating the remaining half of the immune complexes on SDS ± PAGE and analysing using anti-Fak or Pyk2 antibodies. Non-speci®c background densities were assessed from the same lysate immunoprecipitated with an irrelevant antibody. Speci®c densities were determined by subtracting the non-speci®c densities from the total densities assessed with anti-phosphotyrosine antibodies. Speci®c activities of each kinase were then calculated by dividing the densities of phosphotyrosine by those of protein bands of each kinase.
